Overview
- Quantinuum revised its proposed Nasdaq listing by increasing the price range to $53–$55 per share and raising the share count to 26.5 million, taking the offering target to about $1.6 billion and planning to trade under the ticker QNT.
- Market reports say demand has far outstripped supply and the offering is oversubscribed by a double-digit multiple, though that claim comes from market sources rather than a company-certified filing.
- The company reported $30.9 million in revenue for 2025 and a $192.6 million net loss for 2025, showing revenue growth but continued heavy spending on research and commercialization.
- After the IPO Quantinuum will operate as a holding company whose primary public asset will be roughly a 12.1% economic stake in Quantinuum Holdings, LLC, with that share rising to 13.4% if underwriters buy the full option.
- Quantinuum has reported U.S. federal R&D funding for trapped-ion quantum work and the IPO outcome will be watched for its signal to investors and to public programs about commercial appetite and funding for quantum technology.